Michigan Medicine joins exclusive, global network that helps press gas on linking children with incurable brain cancer to promising clinical trials.
In the lab, Michigan Medicine researchers are developing new approaches to tackling this deadly type of brain cancer.
New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.
Optical imaging and artificial intelligence are making brain tumor diagnosis quicker and more accurate.
Tests that provide molecular details on a specific tumor aren’t routinely done for pediatric brain tumors, but research suggests the extra step could change a child’s therapy.
Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.